Brief: Femasys Secures U.S. FDA Clearance For Next-Generation Femvue Diagnostic Device
18/12/2025 14:47
Dec 18 (Reuters) - Femasys Inc FEMY.O: FEMASYS SECURES U.S. FDA CLEARANCE FOR NEXT-GENERATION FEMVUE DIAGNOSTIC DEVICE Source text: ID:nGNX3ycKmp Further company coverage: FEMY.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview